Nearly $20 million awarded by CPRIT to MD Anderson
Â鶹ӳ» MD Anderson Cancer Center today was awarded $19.6 million from the Cancer Prevention and Research Institute of Texas (CPRIT) to support research, recruitment and prevention efforts. In total, MD Anderson and its projects received 20 percent of the $96 million in awards announced by CPRIT.
MD Anderson awards included $12 million for individual investigator research, including awards for clinical translation...
Small cell lung cancer may respond to combination of immunotherapy and DNA damage repair inhibitors
Researchers at Â鶹ӳ» MD Anderson Cancer Center have discovered that a combination of immune checkpoint blockade and targeted...
Immunotherapy combination generates responses against castration-resistant metastatic prostate cancer
Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy...